Heart Disease Weekly
Susan Hasty, Publisher
Table of Contents . . . August 18th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Heart Disease Weekly | Other Publications
Acute Myocardial Infarction - Drug combo curbs artery reclosing after some heart attacks
Prognosis - Diabetes not a predictor of survival after coronary revascularization surgery
Acute Myocardial Infarction - More patients diagnosed with heart attack under new definition
Cardiac Repair - Growth factor augments revascularization following arterial bypass surgery
Dyslipidemia - Extended-release niacin effective in low doses for diabetes
Hypertension - Control is possible in African American patients with difficult-to-control BP
Alzheimer Disease - New research indicates heart-healthy lifestyle could prevent Alzheimer
Arterial Occlusion - Phase I trial for Alfimeprase initiated
Cardiac Arrest - FDA approves new indication for implantable cardioverter defibrillators
Cardiovascular Disease - American Heart Association updates heart attack, stroke prevention guidelines
Cardiovascular Disease - Obesity, diabetes epidemics could intensify heart disease prevalence
Cholesterol - Loaded liposomes lower serum cholesterol in hereditary hypercholesterolemia
Congestive Heart Failure - Direct injection of gene into coronary artery provides longer-lasting treatment
Congestive Heart Failure - Treatment shows success in animal model
Coronary Artery Disease - QMed begins Medicare demonstration
Deep-Vein Thrombosis - Long distance air travelers advised to know risk factors and how to prevent DVT
Disease Association - Atorvastatin, with or without fish oil, reduces levels of substances implicated in atherosclerosis
Financing - Volcano Therapeutics completes $24 million round of financing
Health Information Management - Program tracks stroke treatment
Heart Disease - Results of novel predictive modeling study presented
Heart Disease - Study: Risk of side effects from heart drugs is lower than previously thought
Hormone Replacement Therapy - HERS II finds HRT has neutral effect on preexisting heart disease
Hypertension - Aromasin approved in Japan; Pharmacia submits NDA for Eplerenone in hypertension
Hypertension - Par Pharmaceutical to begin shipment of tizanidine 2 mg and 4 mg tablets and lisinopril tablets
Hypertension - Ranbaxy gets approval for commercialization of lisinopril hydrochlorothiazide
Hypertension - Watson receives FDA approval for lisinopril and lisinopril/HCTZ tablets
Myocardial Infarction - Prehospital administration of Retavase can accelerate important heart-attack treatment
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
